A research programme by the Access to Medicine Foundation
The foundation

Access to Medicine Foundation

The Foundation stimulates and guides pharmaceutical companies to do more to improve access to medicine. It is an independent non-profit organisation.
Our programmes

Access to Medicine Index

Ranks 20 of the world’s largest pharmaceutical companies based on their efforts to address access to medicine, including in strategy, governance, R&D and pricing. By publicly recognising the best performers, the Index spurs companies to compete to be the best.

Antimicrobial Resistance Benchmark

Tracks what the 30 most active companies in antimicrobial R&D and manufacturing are doing to bring antimicrobial resistance under control. By assessing the level of action, it provides a reality check on progress against AMR.

Access to Vaccines Index

Reports what vaccine companies are doing to ensure all children can be immunised wherever they live. By uncovering what is working and where, this Index helps ensure vaccine markets also reach the poorest and most remote communities.
Type search term(s) and press enter
Often searched for
Index Ranking Vacancies 10-year analysis R&D pipelines AMR antibiotics Investors
  • In the media
  • WHO sounds alarm over COVID-linked oxygen cri...
Media - published on 02 Mar 2021
Share

WHO sounds alarm over COVID-linked oxygen crisis

Lianna Matt McLemon for CIDRAP writes about the shortage of medical oxygen in low- and middle-income countries (LMICs) that has been exacerbated by COVD-19.

Explore further

News

Bridging the gap in access to oxygen: Foundation coordinates on key actions for industry

Oxygen is critical in the treatment of pneumonia, which claims the lives of more than 672,000 children under 5 every year. Further, one in five COVID-19 patients will each need access to oxygen in vast quantities. The Access to Medicine Foundation and the Every Breath Counts Coalition are exploring opportunities to increase access to medical oxygen in low and middle-income countries (LMICs) along with industry, investors, and global health agencies.
Media

4 principles for urgent pharma action to combat COVID-19

Drawing on the findings from the 2021 Access to Medicine Index, the Norwegian government, which co-chairs the Facilitation Council of the ACT-Accelerator, has proposed four principles for urgent pharma action to ensure equity to COVID-19 vaccines and treatments in low- and middle-income countries (LMICs).
Publication

Fortune: Gasping for breath: Covid-19 exposes medical oxygen crisis and need for industry action

In this viewpoint for Fortune Magazine, Access to Medicine Foundation Executive Director Jayasree K. Iyer addresses the urgent need for medical oxygen in low- and middle-income countries (LMICs), examining the role of pharmaceutical companies and how existing needs amplified due to COVID-19.

Get in touch

Back to top |